logo

HITAP เข้าสู่ระบบ

ลืมรหัสผ่าน?

A synthesis of policy recommendations on economic evaluation of biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) for the treatment of rheumatoid arthritis patients with high disease activity

Home > Research Projects > Strategy 3 : HTA Research > A synthesis of policy recommendations on economic evaluation of biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) for the treatment of rheumatoid arthritis patients with high disease activity

Project Code

63111002RM009L0

Research team

Researchers

Pattara Leelahavarong, PhD.

Co - Researcher

Songyot Pilasant

ภญ.จุฑามาศ พราวแจ้ง

Chonticha Chanjam

Project Details

Strategies
Category
Support
Tags
Country

Project duration

Start: 20 April 2020
End: 19 October 2020

Contact
[email protected]

Project Status

Conducting Research - 38%

Viewer: 643

Publish date2 June 2020 12:02

Documents

Activity

Health Intervention and Technology Assessment Program Foundation
Head Office : 88/22 Moo 4, 6th Building, 6th Floor, Department of Health, Ministry of Public Health, Tiwanon Road, Taladkwan Subdistrict, Muang Nonthaburi District, Nonthaburi 11000, Thailand


Tel. : +662-590-4549, +662-590-4374-5
Fax : +662-590-4369
E-mail : [email protected]
Website : www.hitap.net


© Copyright - HITAP 2014
Top